Cervical cancer is one of the few cancers that is almost entirely preventable – and in Aotearoa, we’re making real progress ...
Editor's Note: One hundred years ago, Dr. George Papanicolaou first put vaginal smears under the microscope to study human vaginal cytology, using samples supplied by his wife. [1] Dr. Papanicolaou ...
Abbott Laboratories is adding HPV screening to its "Alinity m" family of diagnostic assays following U.S. Food & Drug Administration approval. Abbott said in a press release that the FDA approved its ...
HPV testing 8 years after negative result was comparable to risk after 3 years in cytology cohort. HealthDay News — Primary human papillomavirus (HPV) screening intervals could be extended, with the ...
ABBOTT PARK, Ill., Nov. 2, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) has received U.S. Food and Drug Administration (FDA) approval for its molecular human papillomavirus or HPV screening solution, ...
(CNN) — Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30, according to a ...
Cervical screening aims to prevent invasive cervical cancer by detecting abnormalities in a woman's cervix which can be a precursor to cancer. In cytology-based screening, the cells taken during the ...
The U.S. Food and Drug Administration (FDA) has approved a human papillomavirus (HPV) DNA test for women 25 and older that can be used to determine whether these women should have additional ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results